You are here: Industry Insights > antidepressant

News List

Chinese scientists develop non-hallucinogenic antidepressant compounds FirstWordPharma
January 29, 2022
Chinese scientists designed two new compounds that they say can relieve depression, but do not cause the unwanted effect of hallucination, reported Xinhua.
Phytomedicine Saffron in The Treatment of Depression and It’s Potential Effects Lin Zhang
January 15, 2020
There has been an increasing studies on Saffron use in medical condition within the last two decades.
Common Antidepressants May Work in Unexpected Way drugs
September 24, 2019
Many people who take the antidepressant Zoloft report feeling better. But new research suggests the drug may be treating their anxiety, rather than their depression, at least in the early weeks.
Possible link between autism and antidepressants use during pregnancy worldpharmanews
May 05, 2019
Possible link between autism and antidepressants use during pregnancy.
Anti-Inflammatory Add-On May Be Beneficial for Depression drugs
April 19, 2019
Anti-Inflammatory Add-On May Be Beneficial for Depression.
Benzodiazepines could decrease mortality in congestive heart failure europeanpharmaceuticalreview
April 10, 2019
Researchers have suggested that benzodiazepines should be the first course of treatment for those with cardiovascular disease and anxiety…
No association found between trazodone and reduced risk of dementia europeanpharmaceuticalreview
April 10, 2019
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia…
FDA panel backs Sage’s novel antidepressant but turns down Alkermes’ pharmaphorum
December 14, 2018
Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee at its meeting last week, but the same panel had bad news for Alkermes’ two-drug therapy....
FDA staff spotlight big—but expected—issues on Alkermes' depression drug fiercebiotech
November 02, 2018
The FDA raised significant—but expected—concerns about Alkermes’ major depressive disorder drug ALKS-5461 in briefing documents released (PDF) ahead of an advisory committee
Opioid Addicts Turning to Unapproved Antidepressant to Get High drugs
August 03, 2018
In a trend that suggests opioid addicts are turning to new fixes, a government report shows that use of an unapproved antidepressant is becoming more widespread in the United States.

Previous page 1 2 Next page